Medical Affairs Outsourcing Market to Access Global Industry Players like Key Players – Icon plc, The Medical Affairs Company (TMAC), Iqvia Holdings Inc., Syneos Health Inc., Ashfield Healthcare Communications, Pharmaceutical Product Development, LLC
The Global Medical Affairs Outsourcing Market report, published by Adroit Market Research, is an extensive compilation of the essential aspects [...]
Prescription drug price reform on the line in Biden’s big social spending bill
Republishing Guidelines ▪ You must give Wisconsin Examiner credit, including https://wisconsinexaminer.com and author. ▪ If you publish online, include the [...]
Relationships between developmental strategies for additional indications and price revisions for anticancer drugs in Japan
- Research - Open Access - [Published:] Relationships between developmental strategies for additional indications and price revisions for anticancer drugs [...]
Real World Evidence : Need To Access Opinions On Diseases and Treatments Across Social Media
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs. The monitoring of [...]
Use of Real World Evidence (RWE) and AI to enable better clinical care
During the prescribing process, a physician’s ability to accurately and reliably match the most appropriate therapy option to the patient [...]
Patient Portal Market Size, Share, Trends, Forecast 2022-27
According to IMARC Group latest report titled” Patient Portal 2022-2027”, the market reached a value of US$ 2.7 Billion in [...]
Abbvie Calls for U.S. International Trade Commission Investigation of Alvotech’s Humira Biosimilar
The manufacturer Abbvie has formally asked the U.S. International Trade Commission to investigate Alvotech’s lower-cost Humira biosimilar. Alvotech has faced [...]
Experts in Alzheimer’s Recommend Accelerated Withdrawal for Aduhelm
A group of medical professors and expert researchers in Alzheimer’s disease have asked the FDA to quickly withdraw their approval [...]
Patients Rising Podcast: Healthcare Policy Changes in 2022
The landscape of upcoming healthcare policy in 2022 is the focus of the latest episode of the Patients Rising Podcast. [...]
House Democrats survey reveals that pharmaceutical companies have pushed price increases in the U.S.
Introduction of survey results, House Oversight Chair Carolyn Maloney (DN.Y.) Dismisses the pharmaceutical industry’s claim that drug prices dominate. The [...]
Most Expensive Drug in Oregon Costs Nearly $420,000 – The Corvallis Advocate
According to The Lund Report , one Oregon man needed a life-saving medication after learning a rare genetic mutation was [...]
Bioengineered Protein Drugs Market: Growing Significance of Preventive Care In the Healthcare Sector Is Improving Sales
According to Fact MR’s recent market research, Bioengineered Cancer Drugs sales to swell at propelled CAGR through 2031, as investment [...]
Pharmaceutical companies picking out the US to stop inflation and raise prices: Survey
According to a three-year parliamentary survey released Friday, the pharmaceutical industry is targeting vulnerable Americans at predatory pricing, forcing them [...]
2022 Health Trends Report Released by Syneos Health
Syneos Health has just released their 2022 Health Trends: Insights for Industry Change Agents report. The key trends for the [...]
Healthcare Spending by the Numbers: New NHE Data
National Health Expenditures (NHE) data was recently released by the Centers for Medicare & Medicaid Services (CMS) for 2020. The [...]
Genesis Research Enhances EVID AI
EVID AI, the most extensive research platform for current healthcare literature, has been enhanced by the health economics and outcomes [...]
Vaccines and Value Assessment – 7 Updates
Navigating the evaluation requirements from health technology assessment (HTA) agencies and national immunization technical agency groups (NITAGs) is a must [...]
ISPOR 2022: Call for Abstracts
ISPOR is requesting submissions for their ISPOR 2022 conference, taking place from May 15th-18th, 2022. Applicants can submit abstracts for [...]
Digital Health Technology Approval and Evidence in Germany
The previous approach to digital health technology assessment in Germany was considered rigid by many in the industry. However, with [...]
Patient Centricity Vs. Patient Engagement
While patient engagement is critically important, Dr. Anthony Yanni, Vice President at Astellas Pharma, argues that moving the goal to [...]
NICE’s 5-Year Strategy Signals a More Collaborative Approach.
The UK’s National Institute for Health and Care Excellence (NICE) new health technology assessment manual signals a push towards greater [...]
AMCP Releases Board Election Results
The Academy for Managed Care Pharmacy (AMCP) has announced the results of their 2022-2023 board elections. These include their new [...]
The Future of Telehealth for Outpatient Mental Healthcare is Uncertain
Intensive outpatient therapy moved to a telehealth model for safety reasons during the COVID-19, but whether this new model will [...]
Final ICER Evidence Report on Tezepelumab for Severe Asthma
A final evidence report for the clinical effectiveness and value of Tezepelumab, a treatment for severe asthma, has been released [...]
Major Telehealth Companies Team Up In Preparation of Tightening Regulations
Companies providing telehealth services and platforms are teaming up with lobbyists to push back against the retightening of regulations loosened [...]